MARKET

KZIA

KZIA

Kazia Therapeuti
NASDAQ
5.00
-1.89
-27.43%
After Hours: 5.87 +0.87 +17.40% 18:31 01/02 EST
OPEN
6.87
PREV CLOSE
6.89
HIGH
6.96
LOW
5.00
VOLUME
354.84K
TURNOVER
--
52 WEEK HIGH
17.40
52 WEEK LOW
2.860
MARKET CAP
53.66M
P/E (TTM)
-0.4028
1D
5D
1M
3M
1Y
5Y
1D
Kazia Therapeutics trading resumes
TipRanks · 2h ago
Kazia Therapeutics trading halted, volatility trading pause
TipRanks · 2h ago
Weekly Report: what happened at KZIA last week (1222-1226)?
Weekly Report · 12/29/2025 09:08
Is the Market Bullish or Bearish on Kazia Therapeutics Ltd?
Benzinga · 12/26/2025 17:00
Kazia Therapeutics Raises $50 Million in Private Placement
Reuters · 12/22/2025 13:02
KAZIA THERAPEUTICS REGAINS FULL NASDAQ LISTING COMPLIANCE
Reuters · 12/22/2025 13:00
Weekly Report: what happened at KZIA last week (1215-1219)?
Weekly Report · 12/22/2025 09:08
Kazia Therapeutics files to sell 10.7M American depositary shares for holders
TipRanks · 12/19/2025 21:50
More
About KZIA
Kazia Therapeutics Limited is an Australia-based pharmaceutical drug development company. The Company operates in the pharmaceutical research and development business. The Company’s lead program is paxalisib, an investigational brain-penetrant inhibitor of the PI3K / Akt / mTOR pathway, which is being developed to treat multiple forms of brain cancer. It is also developing EVT801, a small-molecule inhibitor of VEGFR3, which is critical to the development of new blood vessels and lymphatic vessels in a growing tumor, as well as to the metastasis of tumors to distant sites in the body. It designed paxalisib to inhibit PI3K, a critical control mechanism in growth and cell division, which is activated in many forms of cancer. The Company’s drug candidates are designed to treat diseases, such as brain cancer, renal cancer, and liver cancer.

Webull offers Kazia Therapeutics Ltd (ADR) stock information, including NASDAQ: KZIA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, KZIA stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading KZIA stock methods without spending real money on the virtual paper trading platform.